Site Map | Links | Contact Us

About Proxinium
Proxinium™ is an investigational medication that is being used in clinical trials to treat advanced squamous cell cancer located in the head and neck.

Head and Neck Cancer
Head and neck cancer is the 6th most common cancer globally, with approximately 55,000 new cases diagnosed annually in the U.S. alone, leading to 14,000 deaths annually


The content of this site is for informational purposes only and is not intended to replace the advice of a health care professional. Please consult your doctor if you have any questions regarding the information contained in this site.